| Overview |
| bsm-90167r-50µL |
| Rho GTPase activating protein 5 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human RhoGAP |
| 1150-1250/1502 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 394 |
| Q13017 |
| ARHGAP5; Rho GTPase Activating Protein 5; P190-B; Rho-Type GTPase-Activating Protein 5; Rho GTPase-Activating Protein 5; Growth Factor Independent 2; P190BRhoGAP; RhoGAP5; RHOGAP5; GFI2; P100 RasGAP-Associated P105 Protein; P105 RhoGAP; P190BRHOGAP |
| Cell Line: Hela Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |